Frequently Asked Questions

We provide comprehensive, evidence-informed alternative and  integrative cancer care built around repurposed medications like ivermectin and mebendazole — but our services go far beyond a prescription. Every patient journey begins with an in-depth clinical evaluation of your full medical history, pathology, genetics, and current treatment regimen. From there, we design a fully personalized protocol that typically includes:

• Precision-dosed cancer protocols using ivermectin, mebendazole, and select supportive repurposed medications, with ongoing adjustment based on your response and lab monitoring.
•  Metabolic and nutritional oncology support — targeted dietary strategies, therapeutic supplementation, and lifestyle interventions designed to starve cancer cells and strengthen your body’s defenses.
•  Integrative co-management — we actively coordinate with your local oncologist and care team to safely layer our therapies alongside conventional treatments like chemotherapy, radiation, or immunotherapy, never asking you to choose one over the other.
• Continuous monitoring and guidance through regular follow-up consultations, blood work reviews, and protocol evolution as your condition and the science change.
• Essentially, we serve as your dedicated integrative oncology navigator — filling the evidence-shaped gaps that standard care often leaves behind, and providing a clear, actionable roadmap when you’ve been told there are no more options.

Everything starts with a private consultation where we determine if our approach is right for your specific case.

Getting started is simple and free of pressure. When you schedule your initial consultation, you’ll receive a secure intake form to capture your detailed health story.

During the consultation, I will review your case in depth, discuss which integrative strategies — including ivermectin, mebendazole, and supporting therapies — might be appropriate for your specific situation, and map out a provisional, personalized treatment plan. You’ll leave with clarity, not confusion.

It’s a focused, science-backed conversation designed to give you real hope and an actionable path forward, regardless of where you are in your cancer journey. Click here to request a Consultation!

We work with patients across a broad spectrum of solid tumors and hematologic malignancies — including breast, colon, lung, prostate, pancreatic, and brain cancers, among others — as well as those managing late-stage or treatment-resistant disease. Because these repurposed drugs target fundamental metabolic and cellular pathways common to many cancers, a wide range of patients may benefit. Candidate suitability is determined through a thorough review of your medical history, pathology reports, and current health status, which is exactly what we assess during your initial deep-dive consultation. Even if you’ve been told there are no more options, it’s worth a conversation.

It’s a common misconception. Both ivermectin and mebendazole are well-studied, Nobel Prize-honored medicines originally developed for humans, with decades of safety data. What many people don’t know is that a growing body of peer-reviewed research has revealed their powerful off-target anticancer properties — including the ability to disrupt cancer cell metabolism, inhibit tumor stem cells, and make aggressive cancers more vulnerable to the body’s own immune defenses. In our integrative protocols, we use pharmaceutical-grade, precisely dosed forms of these medications as part of a comprehensive strategy, not as a standalone miracle. The real power lies in how they’re combined with targeted nutrition, lifestyle shifts, and immune support to create an environment where cancer struggles to survive.

It’s a common misconception. Both ivermectin and mebendazole are well-studied, Nobel Prize-honored medicines originally developed for humans, with decades of safety data. What many people don’t know is that a growing body of peer-reviewed research has revealed their powerful off-target anticancer properties — including the ability to disrupt cancer cell metabolism, inhibit tumor stem cells, and make aggressive cancers more vulnerable to the body’s own immune defenses. In our integrative protocols, we use pharmaceutical-grade, precisely dosed forms of these medications as part of a comprehensive strategy. The real power lies in how they’re combined with targeted nutrition, lifestyle shifts, and immune support to create an environment where cancer struggles to survive.

You’re not alone in asking this — it’s the question that brings many people to our door. The short answer is that the clinical research, while robust and rapidly accumulating, exists largely outside the heavily funded big pharma mainstream because these are inexpensive, generic drugs that can’t be patented for cancer. There are now dozens of preclinical and human observational studies, multiple ongoing clinical trials, and thousands of patient case reports showing meaningful responses. Our medical team stays at the leading edge of this science, translating research into real-world protocols that respect both the evidence and your individual biology. We simply follow where the data leads — not where profit margins dictate.